Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Van Anh Trinh

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 17, 2008
Current management of metastatic melanomaVan Anh Trinh
Journal of the Advanced Practitioner in Oncology|September 2, 2015
Managing Side Effects of Vemurafenib Therapy for Advanced MelanomaBrenda Hagen, Van Anh Trinh
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 11, 2012
Ipilimumab for advanced melanoma: a pharmacologic perspectiveVan Anh Trinh, Brenda Hagen
The Annals of Pharmacotherapy|July 25, 2014
Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue"Anthony Jarkowski, LeAnn Norris, Van Anh Trinh
Expert Opinion on Drug Safety|June 20, 2017
The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanomaVan Anh Trinh, Chrystia Zobniw, Wen-Jen Hwu
Chinese Clinical Oncology|April 6, 2015
Treatment of BRAF-mutated advanced cutaneous melanomaVan Anh Trinh, Yan You, Wen-Jen Hwu
Discovery Medicine|February 22, 2018
Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma -- a clinical updateVan Anh Trinh, Jocelyn Joseph, Wen-Jen Hwu
Expert Opinion on Biological Therapy|September 25, 2014
Ipilimumab in the treatment of advanced melanoma - a clinical updateDae Won Kim, Van Anh Trinh, Wen-Jen Hwu
Expert Opinion on Drug Safety|May 14, 2009
The safety of temozolomide in the treatment of malignanciesVan Anh Trinh, Sapna Pradyuman Patel, Wen-Jen Hwu
Discovery Medicine|June 25, 2015
Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanomaWhitney Metcalfe, Jaime Anderson, Van Anh Trinh, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 17, 2008
Current management of metastatic melanomaVan Anh Trinh
Journal of the Advanced Practitioner in Oncology|September 2, 2015
Managing Side Effects of Vemurafenib Therapy for Advanced MelanomaBrenda Hagen, Van Anh Trinh
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 11, 2012
Ipilimumab for advanced melanoma: a pharmacologic perspectiveVan Anh Trinh, Brenda Hagen
The Annals of Pharmacotherapy|July 25, 2014
Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue"Anthony Jarkowski, LeAnn Norris, Van Anh Trinh
Expert Opinion on Drug Safety|June 20, 2017
The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanomaVan Anh Trinh, Chrystia Zobniw, Wen-Jen Hwu
Chinese Clinical Oncology|April 6, 2015
Treatment of BRAF-mutated advanced cutaneous melanomaVan Anh Trinh, Yan You, Wen-Jen Hwu
Discovery Medicine|February 22, 2018
Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma -- a clinical updateVan Anh Trinh, Jocelyn Joseph, Wen-Jen Hwu
Expert Opinion on Biological Therapy|September 25, 2014
Ipilimumab in the treatment of advanced melanoma - a clinical updateDae Won Kim, Van Anh Trinh, Wen-Jen Hwu
Expert Opinion on Drug Safety|May 14, 2009
The safety of temozolomide in the treatment of malignanciesVan Anh Trinh, Sapna Pradyuman Patel, Wen-Jen Hwu
Discovery Medicine|June 25, 2015
Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanomaWhitney Metcalfe, Jaime Anderson, Van Anh Trinh, et al.
Pageof 3